Mühle, C.; Wagner, C.J.; Färber, K.; Richter-Schmidinger, T.; Gulbins, E.; Lenz, B.; Kornhuber, J.
Secretory Acid Sphingomyelinase in the Serum of Medicated Patients Predicts the Prospective Course of Depression. J. Clin. Med. 2019, 8, 846.
https://doi.org/10.3390/jcm8060846
AMA Style
Mühle C, Wagner CJ, Färber K, Richter-Schmidinger T, Gulbins E, Lenz B, Kornhuber J.
Secretory Acid Sphingomyelinase in the Serum of Medicated Patients Predicts the Prospective Course of Depression. Journal of Clinical Medicine. 2019; 8(6):846.
https://doi.org/10.3390/jcm8060846
Chicago/Turabian Style
Mühle, Christiane, Claudia Johanna Wagner, Katharina Färber, Tanja Richter-Schmidinger, Erich Gulbins, Bernd Lenz, and Johannes Kornhuber.
2019. "Secretory Acid Sphingomyelinase in the Serum of Medicated Patients Predicts the Prospective Course of Depression" Journal of Clinical Medicine 8, no. 6: 846.
https://doi.org/10.3390/jcm8060846
APA Style
Mühle, C., Wagner, C. J., Färber, K., Richter-Schmidinger, T., Gulbins, E., Lenz, B., & Kornhuber, J.
(2019). Secretory Acid Sphingomyelinase in the Serum of Medicated Patients Predicts the Prospective Course of Depression. Journal of Clinical Medicine, 8(6), 846.
https://doi.org/10.3390/jcm8060846